Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent

Bioorganic & Medicinal Chemistry Letters
Yoshimi IchimaruShinichi Miyairi

Abstract

Indirubin is a potent inhibitor of cell cycle-related protein kinases by binding to the ATP-binding site and thus is a promising compound for development as an antitumor drug. We prepared indirubin 3'-(O-oxiran-2-ylmethyl)oxime (Epox/Ind), in which the ATP-binding site orientated part was attached by non-specific alkylating group. The IC50 value of Epox/Ind at 1.7 μM in HepG2 cells is comparable to that of cisplatin (4.0 μM). Furthermore, Epox/Ind was shown to be metabolized by a HepG2 cell lysate into indirubin 3'-(O-2,3-dihydroxypropyl)oxime (E804), the sole extractable metabolite. The lower toxicity of this metabolite may explain the lack of cytotoxicity of 1 μM Epox/Ind observed in HepG2 cells beyond an initial loss of viability in the first 24h of treatment.

References

Jun 1, 1992·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·A D Marshall, J Caldwell
Jun 1, 1997·Chemical Research in Toxicology·W W JohnsonF P Guengerich
Jun 27, 2001·The Journal of Biological Chemistry·J AdachiT Matsuda
Aug 17, 2002·The Journal of Biological Chemistry·Tarek AbbasJill Bargonetti
Sep 19, 2002·Trends in Pharmacological Sciences·Marie KnockaertLaurent Meijer
Jan 1, 2004·Chemistry & Biology·Laurent MeijerPaul Greengard
Mar 3, 2005·Chembiochem : a European Journal of Chemical Biology·Rolf JautelatGerhard Siemeister
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sangkil NamRichard Jove
Jul 21, 2006·Journal of Medicinal Chemistry·Yoan FerandinLaurent Meijer
Sep 26, 2008·Journal of Medicinal Chemistry·Konstantina VougogiannopoulouLaurent Meijer
May 22, 2010·Bioorganic & Medicinal Chemistry·Xinlai ChengGerhard Eisenbrand
Nov 22, 2011·The Journal of Biological Chemistry·Juan Manuel DomínguezMiguel Medina
May 5, 2012·BMC Cancer·Eun-Kyung Shin, Jin-Kyung Kim
Jan 22, 2013·ACS Medicinal Chemistry Letters·Vassilios MyrianthopoulosAlexios-Leandros Skaltsounis
Dec 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Phillip A SchwartzBrion William Murray
Jul 30, 2014·European Journal of Pharmacology·Toru TanakaShunsuke Kobayashi

❮ Previous
Next ❯

Citations

Jun 3, 2016·Biological & Pharmaceutical Bulletin·Masahiro KuritaTakashi Suzuki
Jul 26, 2017·Pharmaceutical Biology·Manoela Viar FogaçaIlce Mara de Syllos Cólus
Mar 3, 2020·Biological & Pharmaceutical Bulletin·Yasuhito NobushiYukinaga Kishikawa
Feb 17, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fiona L KearnsH Lee Woodcock
Mar 3, 2020·Frontiers in Pharmacology·Rongchun WangXue Wang

❮ Previous
Next ❯

Related Concepts